Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vyv’s proprietary antimicrobial LED lighting has demonstrated significant reductions of viruses and bacteria on hard surfaces—up to ~97% for non-enveloped viruses like MS2 bacteriophage and SARS-CoV‑2 within eight hours, and over 90% for MRSA/E. coli within twenty-four hours under controlled laboratory conditions. The products are used as a supplement to manual cleaning/disinfection practices across healthcare, food production, transportation, hospitality, education sectors and more.
The company’s technology has been published in peer-reviewed journals such as Nature for its impact on global food safety and healthcare industries.
Not intended or approved for use on critical/semi-critical medical devices.
Pipeline breadth not applicable; product line includes various form factors/applications rather than drug programs.
No clinical trials required; efficacy supported by laboratory testing data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vyv.